RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 6,300,408 5.400% | 1,404,449 (+28.69%) | Filing |
| 2024-05-06 5:57 pm Purchase | 2024-04-26 | 13G | Avidity Biosciences, Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 4,895,959 5.100% | 2,441,426 (+99.47%) | Filing |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 2,454,533 3.300% | -3,000,000 (-55.00%) | Filing |
| 2022-12-30 4:30 pm Purchase | 2022-12-20 | 13G | Avidity Biosciences, Inc. RNA | RA CAPITAL MANAGEMENT L.P. | 5,454,533 8.210% | 5,454,533 (New Position) | Filing |